Related Experiment Video
Updated: Mar 28, 2026

11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
8.1K
A review on carrier systems for bone morphogenetic protein-2
1Department of Medical Devices, National Institute of Pharmaceutical Education and Research-Ahmedabad, Ahmedabad-, 380054, India.
Summary
Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive agent for bone defects. This review evaluates various BMP-2 delivery systems and modifications to improve bone regeneration efficacy.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Engineering
Background:
- Bone morphogenetic protein-2 (BMP-2) exhibits significant osteoinductive properties, making it a crucial therapeutic agent for nonunion bone defects.
- Various carriers, including hydrogels, microspheres, nanoparticles, and fibers, have been developed for controlled BMP-2 delivery.
- Existing delivery systems face challenges such as ectopic growth, reduced protein delivery, and protein inactivation.
Purpose of the Study:
- To comprehensively review and evaluate existing carrier systems for BMP-2 delivery.
- To assess different biomaterials (metals, ceramics, polymers, composites) used as carriers.
- To examine strategies for modifying BMP-2 or its delivery systems to enhance therapeutic outcomes.
Main Methods:
- Systematic review of literature on BMP-2 carrier systems.
- Evaluation of carriers based on processing conditions, loading capacity, and release kinetics.
- Analysis of protein modification techniques, including functionalization and peptide extraction.
Main Results:
- Diverse carrier materials (metals, ceramics, polymers, composites) have been explored for BMP-2 delivery.
- Carrier systems influence cell adhesion, degradation, and site-specific protein release.
- Reported limitations include ectopic bone formation and suboptimal protein delivery/activity.
Conclusions:
- There is a critical need to optimize current BMP-2 delivery systems and explore novel biomaterials.
- Modifying BMP-2 itself or its carriers is essential to overcome existing challenges and improve bone regeneration.
- Further research into advanced carrier designs and protein engineering is warranted for effective nonunion bone defect treatment.

